Skip to main content
. 2020 Jul 30;106(9):2397–2404. doi: 10.3324/haematol.2020.252817

Figure 2.

Figure 2.

Distribution of molecular response and driver mutations among patients with or without additional mutations. (A) Patients without additional mutations (n=8). (B) Patients with additional mutations (n=8). MMR: major molecular remission; PMR: partial molecular remission; NR: no remission; JAK2: JAK2 V617F; CALR: CALR mutation; MPL: MPL mutation.